FDA Drug Recalls

Recalls / Class II

Class IID-133-2013

Product

PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.

Affected lot / code info
Lot #: 68581A, 68581B, 68382A, 68382B, 68578A, 68578B, 68579A, 68580A, 68582A, 68582B, Exp 01/15

Why it was recalled

Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.

Recalling firm

Firm
West-ward Pharmaceutical Corp.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
465 Industrial Way W, N/A, Eatontown, New Jersey 07724-2209

Distribution

Quantity
60,289 bottles
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2012-12-05
FDA classified
2013-01-18
Posted by FDA
2013-01-30
Terminated
2014-05-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-133-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls